Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Ghassan Al-Duhaini to replace Abu Shabab as Popular Forces leader in Gaza - 2Step by step instructions to Pick the Right Dental specialist for Your Teeth Substitution
- 34 African Vacationer Locations
- 4Unusual 'ingredients' helped stars form in a galaxy near the Milky Way
- 5Poll: 62% of Americans would oppose U.S. military action in Greenland
- The most effective method to Offset Album Rates with Liquidity Needs
- Paraplegic engineer becomes the first wheelchair user to blast into space
- China’s new condom tax will prove no effective barrier to country’s declining fertility rate
- Robyn returns to music with 'Dopamine,' her 1st single in 7 years: 'Came to save music once again'
- Opening Potential: Self-awareness and Long lasting Learning
- Nature's Treats: 10 Organic products That Lift Prosperity
- Advocacy groups react after Mattel introduces 1st Barbie doll with autism
- Manual for Big name Work out schedules
- A Manual for Nations to Head out To
